(Q78800310)
Statements
High percentage of CD34-positive cells in autologous AML peripheral blood stem cell products reflects inadequate in vivo purging and low chemotherapeutic toxicity in a subgroup of patients with poor clinical outcome (English)
Feller N
Schuurhuis GJ
van der Pol MA
Westra G
Weijers GW
van Stijn A
Huijgens PC
Ossenkoppele GJ